CPC C12N 5/0663 (2013.01) [A61K 38/178 (2013.01); A61K 47/6911 (2017.08)] | 6 Claims |
1. A method for ameliorating liver damage, improving glucose resistance, reducing TNF-α levels, inflammation, and hepatitis in a subject, comprising administering to the subject an effective amount of P-selectin mobilized circulating stem cells (PselMSCs) or P-selectin mobilized circulating stem cell-derived microvesicles (PselSCMVs).
|